BioSpace News Archive

Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) (“CBMG” or the “Company”), a biopharmaceutical firm engaged in the drug development of immunotherapies for cancer and stem cell therapies for degenerative diseases, is scheduled for a presentation at the 25th Annual Conference of the Chinese Biopharmaceutical Association-USA (CBA) to be held online August 29-30, 2020.

The National Kidney Foundation (NKF) is proud to announce Imperial Headwear as a new National Promotional Partner of the NKF Konica Minolta Golf Classic , which to date has raised more than $100 million to promote kidney health and improve the lives of the 37 million Americans affected by kidney disease.

Apic Bio Inc., a gene therapy company developing novel treatment options for patients with rare genetic diseases, today announced the appointment of Jorge A. Quiroz, MD, MBA, as Executive Vice President, Chief Medical Officer.

Metaform, an invention studio, today announced that it had been awarded U.S. Patent No. 10,572,481 by the United States Patent and Trademark Office (USPTO) covering the principles underlying its data fabric software to unify disparate healthcare information sources.

BioIQ, an aggregator of testing solutions and optimizer of lab capacity for leading employers and health plans, today appointed Sean Slovenski as CEO. As the former head of Walmart Health, Slovenski led critical expansions of the company’s healthcare initiatives.

Change Healthcare (Nasdaq: CHNG) today announced it has acquired PROMETHEUS Analytics® from Altarum. PROMETHEUS Analytics is a leading reimbursement approach based on medical episodes of care, used by payer-provider collaborations nationwide, uniquely providing a fair and realistic blueprint for value-based payments.

SleepImage, a technology company offering FDA-cleared cloud-based Software as a Medical Device (SaMD) based on analyzing data collected with a single sensor to evaluate sleep quality and diagnose and manage sleep disorders in children and adults, will join the American Heart Association’s Center for Health Technology & Innovation’s

The Korean Ministry of Food and Drug Safety (MFDS) approved Celltrion’s Investigational New Drug (IND) application to initiate a Phase I trial of CT-P59 in patients By the end of the year Celltrion anticipates global pivotal study results from Phase II/III trials in patients with mild symptoms of COVID-19, the Phase III trial in moderate-to-severe patients, and the prevention trial As part of the prevention clinical trial, Celltrion will

Decision Diagnostics Corp. (OTC PINK:DECN) www.decisiondiagnostics.co, a leading manufacturer and worldwide distributor of diabetic test strips engineered to operate on legacy glucose meters through its subsidiary Pharma Tech Solutions, Inc., today provided the following “Update” on its effort to produce a Covid-19 Swift Kit antigen testing methodologies and secure FDA EUA approval for its products.

Aligos Therapeutics, Inc. (Aligos), a private biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B (CHB), COVID-19 and therapeutics for nonalcoholic steatohepatitis (NASH), will present nonclinical data related to the company’s thyroid hormone receptor-beta (THR-B) therapeutic program for NASH on August 27 at the European Associa